Association of K-ras mutational status and clinical outcomes in patients with metastatic colorectal cancer receiving panitumumab alone.

Freeman DJ, Juan T, Reiner M, Hecht JR, Meropol NJ, Berlin J, Mitchell E, Sarosi I, Radinsky R, Amado RG
Clin Colorectal Cancer. 2008 7 (3): 184-90

PMID: 18621636 · DOI:10.3816/CCC.2008.n.024

MeSH Terms (20)

Adult Aged Aged, 80 and over Antibodies, Monoclonal Antineoplastic Agents Biomarkers, Tumor Clinical Trials, Phase II as Topic Colorectal Neoplasms Disease Progression DNA, Viral Female Humans Male Middle Aged Mutation Panitumumab Proto-Oncogene Proteins ras Proteins Survival Rate Treatment Outcome

Connections (1)

This publication is referenced by other Labnodes entities:

Links